Jim Cramer: This Industrial Company Is 'Absolutely Terrific', Recommends Buying Modine Manufacturing

On CNBC's "Mad Money Lightning Round," Jim Cramer believes in Moderna, Inc. (NASDAQ:MRNA).On May 14, Evercore ISI Group analyst Cory Kasimov initiated coverage on Moderna with an In-Line rating and an

BenzingaMay 15 08:18

Mind Medicine Price Target Cut to $20.00/Share From $29.00 by Oppenheimer

Mind Medicine Price Target Cut to $20.00/Share From $29.00 by Oppenheimer

Dow JonesMay 13 07:44

Oppenheimer Reiterates Outperform on Mind Medicine, Lowers Price Target to $20

Oppenheimer analyst Francois Brisebois reiterates Mind Medicine (NASDAQ:MNMD) with a Outperform and lowers the price target from $29 to $20.

BenzingaMay 13 07:34

Seritage Growth Properties Posts Q1 Loss, Joins Fortrea Holdings And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Monday.Shares of Seritage Growth Properties (NYSE:SRG) fell sharply in today's pre-market trading after

BenzingaMay 13 07:31

Mind Medicine Is Maintained at Buy by HC Wainwright & Co.

Mind Medicine Is Maintained at Buy by HC Wainwright & Co.

Dow JonesMay 10 14:48

HC Wainwright & Co. : Maintaining the Mind Medicine (MNMD.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $75.00 to $35.00.

HC Wainwright & Co. : Maintaining the Mind Medicine (MNMD.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $75.00 to $35.00.

Zhitong FinanceMay 10 14:40